Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaboration.

Cope AP, Barnes MR, Belson A, Binks M, Brockbank S, Bonachela-Capdevila F, Carini C, Fisher BA, Goodyear CS, Emery P, Ehrenstein MR, Gozzard N, Harris R, Hollis S, Keidel S, Levesque M, Lindholm C, McDermott MF, McInnes IB, Mela CM, Parker G, Read S, Pedersen AW, Ponchel F, Porter D, Rao R, Rowe A, Schulze-Knappe P, Sleeman MA, Symmons D, Taylor PC, Tom B, Tsuji W, Verbeeck D, Isaacs JD; RA-MAP Consortium.

Nat Rev Rheumatol. 2018 Jan 24;14(2):119. doi: 10.1038/nrrheum.2018.6.

PMID:
29362468
2.

The RA-MAP Consortium: a working model for academia-industry collaboration.

Cope AP, Barnes MR, Belson A, Binks M, Brockbank S, Bonachela-Capdevila F, Carini C, Fisher BA, Goodyear CS, Emery P, Ehrenstein MR, Gozzard N, Harris R, Hollis S, Keidel S, Levesque M, Lindholm C, McDermott MF, McInnes IB, Mela CM, Parker G, Read S, Pedersen AW, Ponchel F, Porter D, Rao R, Rowe A, Schulz-Knappe P, Sleeman MA, Symmons D, Taylor PC, Tom B, Tsuji W, Verbeeck D, Isaacs JD; RA-MAP Consortium.

Nat Rev Rheumatol. 2018 Jan;14(1):53-60. doi: 10.1038/nrrheum.2017.200. Epub 2017 Dec 7. Review. Erratum in: Nat Rev Rheumatol. 2018 Jan 24;14 (2):119.

PMID:
29213124
3.

Age-related Changes in Bone Marrow Mesenchymal Stromal Cells: A Potential Impact on Osteoporosis and Osteoarthritis Development.

Ganguly P, El-Jawhari JJ, Giannoudis PV, Burska AN, Ponchel F, Jones EA.

Cell Transplant. 2017 Sep;26(9):1520-1529. doi: 10.1177/0963689717721201.

4.

Serum IL-7 as diagnostic biomarker for rheumatoid arthritis, validation with EULAR 2010 classification criteria.

Burska AN, Neilan J, Chisman RE, Pitaksalee R, Hodgett R, Marzo-Ortega H, Conaghan PG, West R, Emery P, Ponchel F.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):115-120. Epub 2017 Sep 15.

PMID:
28980908
5.

T cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals.

Hunt L, Hensor EM, Nam J, Burska AN, Parmar R, Emery P, Ponchel F.

Ann Rheum Dis. 2016 Oct;75(10):1884-9. doi: 10.1136/annrheumdis-2015-207991. Epub 2015 Dec 1.

6.

Genetic data: The new challenge of personalized medicine, insights for rheumatoid arthritis patients.

Goulielmos GN, Zervou MI, Myrthianou E, Burska A, Niewold TB, Ponchel F.

Gene. 2016 Jun 1;583(2):90-101. doi: 10.1016/j.gene.2016.02.004. Epub 2016 Feb 8. Review.

PMID:
26869316
7.

Mesenchymal Stem Cell Alterations in Bone Marrow Lesions in Patients With Hip Osteoarthritis.

Campbell TM, Churchman SM, Gomez A, McGonagle D, Conaghan PG, Ponchel F, Jones E.

Arthritis Rheumatol. 2016 Jul;68(7):1648-59. doi: 10.1002/art.39622.

8.

Lead-Free α-La₂WO₆ Ferroelectric Thin Films.

Carlier T, Chambrier MH, Ferri A, Estradé S, Blach JF, Martín G, Meziane B, Peiró F, Roussel P, Ponchel F, Rèmiens D, Cornet A, Desfeux R.

ACS Appl Mater Interfaces. 2015 Nov 11;7(44):24409-18. doi: 10.1021/acsami.5b01776. Epub 2015 Oct 28.

PMID:
26477357
9.

Changes in peripheral blood immune cell composition in osteoarthritis.

Ponchel F, Burska AN, Hensor EM, Raja R, Campbell M, Emery P, Conaghan PG.

Osteoarthritis Cartilage. 2015 Nov;23(11):1870-8. doi: 10.1016/j.joca.2015.06.018. Epub 2015 Jul 8.

10.

Modulation of peripheral T-cell function by interleukin-7 in rheumatoid arthritis.

Churchman SM, El-Jawhari JJ, Burska AN, Parmar R, Goëb V, Conaghan PG, Emery P, Ponchel F.

Arthritis Res Ther. 2014 Dec 23;16(6):511. doi: 10.1186/s13075-014-0511-3.

11.

Pharmacogenomics in rheumatoid arthritis: how close are we to the clinic?

Ponchel F, Burska AN, Vital EM.

Pharmacogenomics. 2014 Jul;15(10):1275-9. doi: 10.2217/pgs.14.79. No abstract available.

12.

Biomarkers in rheumatoid arthritis.

Goëb V, Fardellone P, Sibilia J, Ponchel F.

Mediators Inflamm. 2014;2014:379310. doi: 10.1155/2014/379310. Epub 2014 Jun 30. No abstract available.

13.

Autoantibodies to posttranslational modifications in rheumatoid arthritis.

Burska AN, Hunt L, Boissinot M, Strollo R, Ryan BJ, Vital E, Nissim A, Winyard PG, Emery P, Ponchel F.

Mediators Inflamm. 2014;2014:492873. doi: 10.1155/2014/492873. Epub 2014 Mar 23. Review.

14.

Cytokines as biomarkers in rheumatoid arthritis.

Burska A, Boissinot M, Ponchel F.

Mediators Inflamm. 2014;2014:545493. doi: 10.1155/2014/545493. Epub 2014 Mar 9. Review.

15.

Gene expression analysis in RA: towards personalized medicine.

Burska AN, Roget K, Blits M, Soto Gomez L, van de Loo F, Hazelwood LD, Verweij CL, Rowe A, Goulielmos GN, van Baarsen LG, Ponchel F.

Pharmacogenomics J. 2014 Apr;14(2):93-106. doi: 10.1038/tpj.2013.48. Epub 2014 Mar 4. Review.

16.

TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes.

Savic S, Ouboussad L, Dickie LJ, Geiler J, Wong C, Doody GM, Churchman SM, Ponchel F, Emery P, Cook GP, Buch MH, Tooze RM, McDermott MF.

J Autoimmun. 2014 May;50:59-66. doi: 10.1016/j.jaut.2013.11.002. Epub 2013 Dec 31.

17.

Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy.

Das S, Vital EM, Horton S, Bryer D, El-Sherbiny Y, Rawstron AC, Ponchel F, Emery P, Buch MH.

Ann Rheum Dis. 2014 May;73(5):909-12. doi: 10.1136/annrheumdis-2013-204417. Epub 2014 Jan 2.

PMID:
24385201
18.

An immunological biomarker to predict MTX response in early RA.

Ponchel F, Goëb V, Parmar R, El-Sherbiny Y, Boissinot M, El Jawhari J, Burska A, Vital EM, Harrison S, Conaghan PG, Hensor E, Emery P.

Ann Rheum Dis. 2014 Nov;73(11):2047-53. doi: 10.1136/annrheumdis-2013-203566. Epub 2013 Aug 29.

PMID:
23989988
19.

Broadband dielectric characterization of sapphire/TiOx/Ba₀.₃Sr₀.₇TiO₃ (111)-oriented thin films for the realization of a tunable interdigitated capacitor.

Ghalem A, Ponchel F, Remiens D, Legier JF, Lasri T.

IEEE Trans Ultrason Ferroelectr Freq Control. 2013 May;60(5):880-7. doi: 10.1109/TUFFC.2013.2645.

PMID:
23661122
20.

Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis.

Strollo R, Ponchel F, Malmström V, Rizzo P, Bombardieri M, Wenham CY, Landy R, Perret D, Watt F, Corrigall VM, Winyard PG, Pozzilli P, Conaghan PG, Panayi GS, Klareskog L, Emery P, Nissim A.

Arthritis Rheum. 2013 Jul;65(7):1702-12. doi: 10.1002/art.37964.

Supplemental Content

Loading ...
Support Center